Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

ESPB for persistent back pain in ankylosing spondylitis

Official title: Efficacy of the Erector Spinae Plane Block for Persistent Back Pain in Patients With Ankylosing Spondylitis

Run by Marmara University · NCT07633730 · Data updated 2026-11-12

This trial tests whether an erector spinae plane block can help reduce persistent back pain in adults with ankylosing spondylitis who still have pain despite controlled disease activity.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment15 (estimated)
SponsorMarmara University
Academic / other
Locations1 site (Istanbul, Pendik)
StatusRecruiting
StartedJune 2, 2026
Main results expectedMay 2, 2027
Study endsJune 2, 2027
Registry record updatedJune 8, 2026
Trial IDNCT07633730 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-65 with ankylosing spondylitis, on treatment that controls disease activity, but with persistent back pain.

Probably not a fit

Patients with contraindications to regional anesthesia or active infection, or those whose back pain is unrelated to inflammatory activity, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study investigates the analgesic effect of the erector spinae plane block (ESPB) in adults with ankylosing spondylitis and ongoing back pain despite treatment aimed at controlling disease activity. Participants receive ESPB as an interventional approach to pain management while continuing standard medical therapy. The trial will assess changes in pain severity and key clinical outcomes over a defined follow-up period. This is one of the first evaluations of ESPB specifically in AS patients with residual pain on treatment. The study is conducted at Marmara University in Istanbul and aims to address unmet need for additional pain relief in this population.

Why it matters

Potential benefit: If successful, patients may experience meaningful reductions in back pain and improvements in function and quality of life.

How similar studies have gone: Prior uses of ESPB in chronic back pain populations suggest potential analgesic benefits, but this specific AS-focused trial is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 65 years
* Diagnosis of ankylosing spondylitis according to the Modified New York Criteria
* Patients receiving ongoing treatment with controlled disease activity but persistent back pain
* Willingness to participate in the study

Exclusion Criteria:

* Body mass index (BMI) greater than 35 kg/m²
* History of thoracic surgery
* Intellectual disability or mental retardation
* Presence of major psychiatric comorbidity
* Congenital spinal anomaly
* Pregnancy
* History of bleeding diathesis
* Presence of active local and/or systemic infection
* Known allergy to the medications to be injected
* Hemodynamic instability
* Active phase of the disease (elevated acute phase reactants, active arthritis findings, etc.)

Where it's running

  • Marmara University Faculty of Medicine Pendik Training and Research Hospital
    Istanbul, Pendik, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Fatma B Akdağ, Research Assistant — Marmara University Faculty of Medicine ,Marmara University, Department of Physical Medicine and Rehabilitation
  • Study coordinator: Fatma B Akdağ, Research Assistant
  • Email: fatma.betul820@gmail.com
  • Phone: +90 537 452 96 60

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.